The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

Donald Trump’s tariff war is too much for his otherwise steadfast ally Senator Ron Johnson, who compared the decision to ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent ...

Wisconsin's two U.S. Senators don't often see eye-to-eye on major issues, but both have concerns about President Trump's pending tariffs.

So, again, I just can't predict where this all goes, but I'm concerned. I don't know what else I can really say,” Johnson said ...

Pregnant women who are incarcerated will move into the facility next week. For now, only women with 18 months or less to ...

"This program is going to give women the building blocks to live a better life, and then that is going to overflow into their ...

Johnson & Johnson’s seltorexant is one of two new therapies that the company reckons could become blockbuster treatments for depression, and data from a phase 3 trial keeps that hope alive.

The key now for Democrats is to fight back not with complaints (which project weakness) but with actions that reclaim the ...

He has been pilloried for his vaccine scepticism, but Robert F Kennedy Jr’s push to reduce America’s reliance on processed ...